These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7693989)

  • 21. The clinical value of serum ferritin in hepatocellular carcinoma.
    Simonetti RG; Craxi A; Dardanonì G; Lanzarone F; Barbaria F; Cottone M; Pagliaro L
    Hepatogastroenterology; 1985 Dec; 32(6):276-8. PubMed ID: 2419233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum erythropoietin concentrations in patients with anemia--preliminary hemoglobin-related reference ranges.
    Vogeser M; Schiel X
    Clin Lab; 2002; 48(11-12):595-8. PubMed ID: 12465743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of a one step sandwich enzymeimmunoassay for serum erythropoietin--serum erythropoietin values in polycythemia vera and related hematological disorders].
    Sawabe Y; Iida S; Tabata Y; Yonemitsu H
    Rinsho Byori; 1993 Jan; 41(1):75-82. PubMed ID: 8355412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of circulating intercellular adhesion molecule 1 in hepatocellular carcinoma.
    Hamazaki K; Gochi A; Shimamura H; Kaihara A; Maruo Y; Doi Y; Orita K; Lygidakis NJ
    Hepatogastroenterology; 1996; 43(7):229-34. PubMed ID: 8682469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of the heterogeneity of des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma.
    Uehara S; Gotoh K; Handa H; Tomita H; Senshuu M
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1545-52. PubMed ID: 16174072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma.
    Pirisi M; Fabris C; Luisi S; Santuz M; Toniutto P; Vitulli D; Federico E; Del Forno M; Mattiuzzo M; Branca B; Petraglia F
    Cancer Detect Prev; 2000; 24(2):150-5. PubMed ID: 10917135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of soluble tumor necrosis factor-p55 levels in the serum and ascitic fluid of patients with hepatocellular carcinoma.
    Gao L; Bai L; Nan QZ; Yang XS; Chen K; Wen HP; Lai ZS; Bo L; Zhang YL; Zhang ZS
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):641-3. PubMed ID: 12376300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients.
    Jin-no K; Tanimizu M; Hyodo I; Nishikawa Y; Hosokawa Y; Endo H; Doi T; Mandai K; Ishitsuka H
    Cancer; 1998 Apr; 82(7):1260-7. PubMed ID: 9529017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
    Zadrazil J; Horák P; Horcicka V; Zahálková J; Strébl P; Hrubý M
    Kidney Blood Press Res; 2007; 30(2):108-16. PubMed ID: 17374961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
    Hsu PI; Chow NH; Lai KH; Yang HB; Chan SH; Lin XZ; Cheng JS; Huang JS; Ger LP; Huang SM; Yen MY; Yang YF
    Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on serum erythropoietin levels in patients with hematologic malignancies].
    Han B; Shi YK; Zhu J; He XH; Lin NJ; Li SL; Shen T
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):543-5. PubMed ID: 17172129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.
    Zhao J; Hu J; Cai J; Yang X; Yang Z
    Chin Med J (Engl); 2003 May; 116(5):772-6. PubMed ID: 12875699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased serum levels of macrophage inflammatory protein-3alpha in hepatocellular carcinoma: relationship with clinical factors and prognostic importance during therapy.
    Yamauchi K; Akbar SM; Horiike N; Michitaka K; Onji M
    Int J Mol Med; 2003 May; 11(5):601-5. PubMed ID: 12684696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.
    Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E
    Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
    Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
    J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
    Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
    Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.